FDA Inspection 1281730 — Frontage Laboratories, Inc.
The FDA completed an inspection of Frontage Laboratories, Inc. on Sep 5, 2025 in Exton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Exton, PA (United States)